Skip to content


STEM appoints Dermot Kenny as new CEO

Leading global pharmaceutical and life sciences auditing firm, STEM, part of Ashfield Advisory, has appointed Dermot Kenny as its new CEO. Dermot has extensive experience in the pharmaceutical industry spanning over 25 years. His most recent role was leading Novartis’ Global Clinical Technology and Innovation team. Throughout his career, he…

Continue Reading